Acutus Medical, Inc. provides revenue guidance for the fourth quarter of 2022. For the period, the company continues to experience year-over-year headwinds related to foreign exchange and capital equipment sales. In late September 2022, the company started to experience disruptions in the supply chain for certain raw materials that negatively impacted revenue in the third quarter of 2022 and is expected to have a further negative impact in the fourth quarter of 2022.

The company now expects revenue to be in a range from $15.5-$16.0 million, which includes incremental headwinds related to both foreign exchange and supply chain pressures.